Star Therapeutics
Star Therapeutics is a clinical-stage biotechnology company headquartered at 201 Haskins Way in South San Francisco, California, that transforms the lives of patients with serious diseases by discovering and developing best-in-class antibody therapies, with an initial focus on hematology and immunology. It operates a hub-and-spoke model, building a family of companies that each pursue a distinct area of novel biology, and it develops each programme under a pipeline-in-a-product strategy in which a single antibody is advanced across multiple related indications rather than one. The company emerged from stealth in February 2022 having raised $100 million since inception, added a $90 million round in September 2023, and closed an oversubscribed $125 million Series D in September 2025 to move its lead asset into a registrational programme. Its two named spokes are Vega Therapeutics, whose VGA039 is a first-in-class monoclonal antibody against Protein S developed as a subcutaneous therapy for von Willebrand disease and other bleeding disorders, and Electra Therapeutics, which targets SIRP proteins with ELA-026 in secondary hemophagocytic lymphohistiocytosis. VGA039 has received FDA Orphan Drug, Fast Track, Rare Pediatric Disease and Breakthrough Therapy designations; Incyte completed its acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in July 2026. Star Therapeutics runs no developer program and publishes no product API, developer portal, or API documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind star-therapeutics.com, catalogued here.
Star Therapeutics publishes 9 APIs on the APIs.io network, including Comments API, Custom Types API, Discovery API, and 6 more. Tagged areas include Company, biotechnology, pharmaceuticals, hematology, and immunology.
Star Therapeutics’ developer surface includes product news, authentication, and 23 more developer resources.
Kin Score
Kin Score
How this is scored →scored 2026-08-12 · rubric v0.11.0
APIs 9
Individual APIs this provider publishes, each with its own machine-readable definition.
Star Therapeutics Comments API
Comment collection. Registered and reachable, but empty — no post on this deployment carries comments.
Star Therapeutics Custom Types API
Avada theme custom post types (avada_faq, avada_portfolio). Registered and anonymously reachable, but both report zero published items.
Star Therapeutics Discovery API
Route, type, taxonomy and status discovery documents.
Star Therapeutics Media API
Media library (661 attachments at harvest time).
Star Therapeutics Oembed API
oEmbed 1.0 provider endpoint for star-therapeutics.com URLs.
Star Therapeutics Pages API
Corporate pages (11 published at harvest time).
Star Therapeutics Posts API
News archive — press releases, news coverage and scientific presentations (28 published at harvest time).
Star Therapeutics Search API
Cross-content search across published objects.
Star Therapeutics Taxonomy API
Categories and tags. Five categories are registered; the post_tag taxonomy is registered but empty.
Scroll for all 9
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 7
Properties that don't map to a standard resource type
Scroll for all 7